Cargando…

Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19), enters affected cells through the angiotensin-converting enzyme 2 (ACE2) receptor, which is highly expressed in type II alveolar cells, enterocytes, and cholangiocytes. SA...

Descripción completa

Detalles Bibliográficos
Autor principal:	Leowattana, Wattana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152453/ https://www.ncbi.nlm.nih.gov/pubmed/34079691 http://dx.doi.org/10.5501/wjv.v10.i3.86

Ejemplares similares

Circulating angiotensin converting enzyme 2 and COVID-19
por: Leowattana, Wattana, et al.
Publicado: (2022)

Dengue hemorrhagic fever and the liver
por: Leowattana, Wattana, et al.
Publicado: (2021)

Potassium-competitive acid blockers and gastroesophageal reflux disease
por: Leowattana, Wattana, et al.
Publicado: (2022)

Chronic hepatitis B: New potential therapeutic drugs target
por: Leowattana, Wattana, et al.
Publicado: (2022)

Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation
por: Leowattana, Wattana, et al.
Publicado: (2022)

Systemic treatment for metastatic colorectal cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Systemic treatments for resectable carcinoma of the esophagus
por: Leowattana, Wattana, et al.
Publicado: (2023)

Immunotherapy for advanced gastric cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

COVID-19 vaccination and cardiac dysfunction
por: Leowattana, Wattana, et al.
Publicado: (2022)

New perspectives on angiotensin-converting enzyme 2 and its related diseases
por: Liu, Li-Ping, et al.
Publicado: (2021)

Systemic treatment for unresectable hepatocellular carcinoma
por: Leowattana, Wattana, et al.
Publicado: (2023)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment
por: Lashgari, Naser-Aldin, et al.
Publicado: (2021)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Rossato, Marco, et al.
Publicado: (2020)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker in coronavirus disease 2019: Safe and possibly beneficial
por: Gupta, Nitesh, et al.
Publicado: (2020)

The potential role of serum angiotensin-converting enzyme in coronavirus disease 2019
por: Zhu, Zhe, et al.
Publicado: (2020)

Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019
por: Suh, Sang Heon, et al.
Publicado: (2021)

Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System
por: Edmonston, Daniel L., et al.
Publicado: (2020)

Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms
por: Xu, Baohui, et al.
Publicado: (2021)

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Komiyama, Maki, et al.
Publicado: (2020)

Inpatient Omission of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With Morbidity and Mortality in Coronavirus Disease 2019
por: Oddy, Christopher, et al.
Publicado: (2021)

Origin and genomic characteristics of SARS-CoV-2 and its interaction with angiotensin converting enzyme type 2 receptors, focusing on the gastrointestinal tract
por: Galanopoulos, Michail, et al.
Publicado: (2020)

Coronavirus disease 2019 in liver transplant patients: Clinical and therapeutic aspects
por: Loinaz-Segurola, Carmelo, et al.
Publicado: (2021)

Angiotensin‐converting enzyme 2 as a versatile player in the management of coronavirus disease 2019
por: Amano, Tetsuya
Publicado: (2020)

The role and significance of angiotensin‐converting enzyme 2 peptides in the treatment of coronavirus disease 2019
por: Liu, Yang, et al.
Publicado: (2021)

Coronavirus disease 2019 severity in obesity: Metabolic dysfunction-associated fatty liver disease in the spotlight
por: Vasques-Monteiro, Isabela Macedo Lopes, et al.
Publicado: (2021)

Clinical features and potential mechanism of coronavirus disease 2019-associated liver injury
por: Han, Mei-Wen, et al.
Publicado: (2021)

Coronavirus disease 2019 and renal transplantation
por: Nassar, Mahmoud, et al.
Publicado: (2021)

Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
por: Sommerstein, Rami, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme Gene Polymorphism and Severe Lung Injury in Patients with Coronavirus Disease 2019
por: Zheng, Haoyi, et al.
Publicado: (2020)

Role and mechanism of angiotensin-converting enzyme 2 in acute lung injury in coronavirus disease 2019
por: Liu, Meng-Yuan, et al.
Publicado: (2020)

Is multisystem inflammatory syndrome related with coronavirus disease 2019, Kawasaki disease, and angiotensin-converting enzyme 2 in children?
por: Eun, Lucy Youngmin
Publicado: (2021)

Preventive treatment of coronavirus disease-2019 virus using coronavirus disease-2019-receptor-binding domain 1C aptamer by suppress the expression of angiotensin-converting enzyme 2 receptor
por: Hameed, Noor S., et al.
Publicado: (2023)

Potential use of the S-protein–Angiotensin converting enzyme 2 binding pathway in the treatment of coronavirus disease 2019
por: Feng, Long, et al.
Publicado: (2022)

Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
por: MITANI, Sawane, et al.
Publicado: (2013)

Viral Proteases as Targets for Coronavirus Disease 2019 Drug Development
por: Zhu, Wei, et al.
Publicado: (2021)

The Cell Biology of the SARS Coronavirus Receptor, Angiotensin-Converting Enzyme 2
por: Lambert, Daniel W.
Publicado: (2009)

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
por: Li, Wenhui, et al.
Publicado: (2003)

Combination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease
por: Vasavada, Nina, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4c0stp8kir68fbfbmhn63djvuu